- 全部删除
- 您的购物车当前为空
Platelet aggregation-IN-3 (Compound 5) 是H2 histamine receptors、α2(A,C)-肾上腺素能受体 (α2-AR) 和5-HT2(B,C) serotonin receptors 的配体。此化合物能够抑制ADP及胶原诱导的血小板聚集,并调节肿瘤细胞诱导的血小板聚集 (TCIPA)。Platelet aggregation-IN-3 有潜力用于心血管疾病的抗血小板治疗,以及预防与癌症相关的血栓形成和肿瘤转移的研究。
Platelet aggregation-IN-3 (Compound 5) 是H2 histamine receptors、α2(A,C)-肾上腺素能受体 (α2-AR) 和5-HT2(B,C) serotonin receptors 的配体。此化合物能够抑制ADP及胶原诱导的血小板聚集,并调节肿瘤细胞诱导的血小板聚集 (TCIPA)。Platelet aggregation-IN-3 有潜力用于心血管疾病的抗血小板治疗,以及预防与癌症相关的血栓形成和肿瘤转移的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | Platelet aggregation-IN-3 (Compound 5) acts as a ligand for H2 histamine receptors, α2(A,C)-adrenergic receptors (α2-AR), and 5-HT2(B,C) serotonin receptors. This compound can inhibit platelet aggregation induced by ADP and collagen, and it also modulates tumor cell-induced platelet aggregation (TCIPA). Platelet aggregation-IN-3 is a promising candidate for anti-platelet therapy in cardiovascular disease and the prevention of cancer-associated thrombosis and tumor metastasis. |
分子量 | 251.755 |
分子式 | C13H18ClN3 |
CAS No. | 1029802-21-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容